Management of autoimmune conditions associated with thymic epithelial tumors [0.03%]
与胸腺上皮肿瘤相关的自身免疫疾病的管理
Waqas Haque,Erica Pietroluongo,Juwairiyyah Fatima et al.
Waqas Haque et al.
Thymic epithelial tumors are associated with diverse autoimmune manifestations, with 30-50% of patients developing at least one autoimmune condition. The pathogenesis involves thymic dysfunction leading to impaired T-cell development and se...
Active surveillance of multifocal ground-glass opacities: results of a prospective multi-center trial (ECTOP1021) [0.03%]
多中心前瞻性观察磨玻璃结节的积极监测项目(ECTOP1021)结果分析
Haoxuan Wu,Fangqiu Fu,Ting Ye et al.
Haoxuan Wu et al.
Introduction: This study aimed to evaluate the safety of active surveillance and establish an individualized management approach for multifocal ground-glass opacities (GGOs). ...
Trajectories of Synchronous Subsolid Nodules in Patients with Resected Subsolid Lung Adenocarcinoma: A Multicenter Cohort Study [0.03%]
亚肺腺癌手术患者的同步亚实性结节的演变特征：多中心队列研究
Yeon Wook Kim,Seyoung Jung,So Jeong Kim et al.
Yeon Wook Kim et al.
Introduction: Multifocal subsolid nodules (SSNs) are increasingly detected with widespread lung cancer screening and advanced thoracic imaging, representing a spectrum of multifocal lung adenocarcinomas (LUADs). When sync...
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial [0.03%]
恩格替尼突变型晚期非小细胞肺癌强化皮肤管理与标准皮肤管理氨imidamab-lazertinib治疗的全球性随机对照试验（COCOON研究）
Byoung Chul Cho,Weimin Li,Alexander I Spira et al.
Byoung Chul Cho et al.
Introduction: Amivantamab plus lazertinib significantly improved progression-free and overall survival versus osimertinib in patients with previously untreated, EGFR-mutant advanced NSCLC. EGFR-targeted therapies are asso...
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database [0.03%]
国际肺癌研究协会分期项目：在国际肺癌研究协会第9版分期数据库初步分析中评估常见分子改变对NSCLC患者总生存期的影响
David P Carbone,Fred R Hirsch,Raymond Uyiosa Osarogiagbon et al.
David P Carbone et al.
Introduction: TNM staging systems create prognostic categories by anatomic extent of disease. Whether therapeutically important molecular alterations in NSCLC augment the prognostic information of TNM staging is unclear. ...
The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM Classification [0.03%]
国际肺癌研究协会分期项目：吸烟状况对第9版TNM分期的影响
Lawson Eng,William K Evans,Megan Eisele et al.
Lawson Eng et al.
Introduction: Cigarette smoking negatively affects lung cancer prognosis. Incorporating smoking history into stage-stratified survival analyses may improve prognostication. ...
Cost-Efficiency of Risk-Based Lung Cancer Screening Across PLCOm2012 Risk Deciles [0.03%]
基于风险的肺癌筛查的成本效率分析——PLCOm2012模型不同风险分位数的效应比较
Chun-Chieh Chen,Shiuan-Chih Chen
Chun-Chieh Chen
A Response to the Letter to the Editor: "Improved Survival With Anatomic Lung Resection Versus Wedge Resection for Stage IA (≤2 cm) NSCLC" [0.03%]
对《针对肺癌小于等于2厘米的IA期患者，解剖性肺切除相较于楔形切除可改善生存率》一文的回复
Christopher W Seder
Christopher W Seder
Improved Survival With Anatomic Lung Resection Versus Wedge Resection for Stage IA (Less Than or Equal to 2 cm) NSCLC [0.03%]
小于等于2厘米的IA期肺癌患者解剖型肺叶切除与楔形切除术后生存状况比较研究
Donghui Jin,Hang Yi,Wenqun Xing
Donghui Jin
A Response to the Letter to the Editor: Cost-Efficiency of Risk-Based Lung Cancer Screening Across PLCOm2012 Risk Deciles [0.03%]
PLCOm2012风险分组千人筛查方案的成本效益回应信
Matthew M Rode,David E Midthun
Matthew M Rode